Principal Investigators

    David Brown


    University of Bath

    Contact information of lead PI


    United Kingdom

    Title of project or programme

    Title: Alpha-Synuclein and Cellular Iron Reduction

    Source of funding information

    Alzheimer's Research UK

    Total sum awarded (Euro)

    € 149,482

    Start date of award


    Total duration of award in years



    Research Abstract

    Brian diseases such as Parkinson’s Disease are likely to be caused by changes to certain brain proteins. While we don’t know how these changes occur we do know what changes occur. In the case of Parkinson’s disease aggregates of a protein called alpha-synuclein can be detected in the brain. One of the difficulties in discovering how these changes occur and how these changes might cause Parkinson’s disease has been not knowing what alpha-synuclein actually does in the brain normally. We have made the first major breakthrough in understanding what alpha-synuclein does. We have shown that it is an enzyme that can change iron to a form more commonly used by cells. This activity known as ferrireductase activity (FR) is likely to have protective effect but increase or loss of this activity might be damaging to cells in the brain.  In this project we will study FR activity of alpha-synuclein and see whether it is changed in disease and  and how change in this activity affects cells. It is possible that the generation of excess reduced iron because of too high alpha-synuclein levels might explain the loss of dopamine cells in the brain of Parkinson’s disease and some other dementias.

    Further information available at:

Types: Investments < €500k
Member States: United Kingdom
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF